New research in kidney cancer, ASCO 2017

被引：0
|
作者：
Basappa, Naveen S. [1 ,2 ]
Kapoor, Anil [3 ]
机构：
[1] Cross Canc Inst, Edmonton, AB, Canada
[2] Univ Alberta, Edmonton, AB, Canada
[3] McMaster Univ, Hamilton, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2017年 / 11卷 / 08期
关键词：
RENAL-CELL CARCINOMA; SUNITINIB;
D O I：
10.5489/cuaj.4840
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：S298 / S300
页数：3
相关论文
共 50 条
  • [41] Current status of research on exosomes in general, and for the diagnosis and treatment of kidney cancer in particular
    Weipu Mao
    Keyi Wang
    Zonglin Wu
    Bin Xu
    Ming Chen
    Journal of Experimental & Clinical Cancer Research, 40
  • [42] Strengthening the foundation of kidney cancer treatment and research: revising the AJCC staging system
    Patel, Hiren V.
    Srivastava, Arnav
    Shinder, Brian
    Sadimin, Evita
    Singer, Eric A.
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [43] Immune Therapy for Kidney Cancer: A Second Dawn?
    McDermott, David F.
    Atkins, Michael B.
    SEMINARS IN ONCOLOGY, 2013, 40 (04) : 492 - 498
  • [44] Sequencing Systemic Therapies for Metastatic Kidney Cancer
    Singh, Parminder
    Agarwal, Neeraj
    Pal, Sumanta K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2015, 16 (01)
  • [45] Immunotherapy for kidney cancer: status quo and the future
    Bedke, Jens
    Stuehler, Viktoria
    Stenzl, Arnulf
    Brehmer, Bernhard
    CURRENT OPINION IN UROLOGY, 2018, 28 (01) : 8 - 14
  • [46] Kidney Cancer An Overview of Current Therapeutic Approaches
    Chowdhury, Nivedita
    Drake, Charles G.
    UROLOGIC CLINICS OF NORTH AMERICA, 2020, 47 (04) : 419 - 431
  • [47] Toxicities of Targeted Therapy and Their Management in Kidney Cancer
    Di Lorenzo, Giuseppe
    Porta, Camillo
    Bellmunt, Joaquim
    Sternberg, Cora
    Kirkali, Ziya
    Staehler, Michael
    Joniau, Steven
    Montorsi, Francesco
    Buonerba, Carlo
    EUROPEAN UROLOGY, 2011, 59 (04) : 526 - 540
  • [48] Novel emerging biomarkers to immunotherapy in kidney cancer
    Ged, Yasser
    Voss, Martin H.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [49] Toxicity Management of Systemic Kidney Cancer Therapies
    Qin, Qian
    Nein, Ellen
    Flaten, Andrea
    Zhang, Tian
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 37 (05) : 993 - 1003
  • [50] Combination therapy in kidney cancer: the next revolution?
    Buti, Sebastiano
    Bersanelli, Melissa
    LANCET ONCOLOGY, 2015, 16 (15) : 1441 - 1442
12345